FDA Adverse Event Malfunction Summary report: N

PEN NDL 32GA 4MM 100 BX 1200 CA

MDR report key: 11083162 · Received December 28, 2020

Report

Report Number
9616656-2020-01294
Event Type
Malfunction
Date Received
December 28, 2020
Date of Event
November 30, 2020
Report Date
April 8, 2021
Manufacturer
BECTON DICKINSON AND CO.
Product Code
FMI
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION: NO SAMPLES (INCLUDING PHOTOS) WERE RETURNED THEREFORE THE COMPLAINT COULD NOT BE CONFIRMED AND THE ROOT CAUSE IS UNDETERMINED. A LOT HISTORY REVIEW WAS CARRIED OUT AND NO RELATED NON CONFORMANCES WERE RAISED IN ASSOCIATION WITH THIS PACKAGED LOT CONCLUDING ALL INSPECTIONS WERE PERFORMED AS PER THE APPLICABLE OPERATIONS AND MET QC SPECIFICATIONS.

Description of Event or Problem · 0

IT WAS REPORTED THAT PEN NDL 32GA 4MM 100 BX 1200 CA WOULD NOT ATTACH AND WAS DIFFICULT TO PRIME. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: MATERIAL NO: 320144 BATCH NO: 0022829. IT WAS REPORTED THAT SOME NEEDLES WILL NOT ATTACH TO THE INSULIN PEN AND THE INSULIN WHEN NOT FLOW WHEN PRIMING.

Additional Manufacturer Narrative · 1

DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED, BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT PEN NDL 32GA 4MM 100 BX 1200 CA WOULD NOT ATTACH AND WAS DIFFICULT TO PRIME. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: MATERIAL NO: 320144, BATCH NO: 0022829. IT WAS REPORTED THAT SOME NEEDLES WILL NOT ATTACH TO THE INSULIN PEN AND THE INSULIN WHEN NOT FLOW WHEN PRIMING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1545791 PEN NDL 32GA 4MM 100 BX 1200 CA PEN NEEDLE FMI BECTON DICKINSON AND CO. 0022829

Patients

Seq Age Sex Outcome Treatment
1